| 000 | 01243 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517070440.0 | ||
| 264 | 0 | _c20160926 | |
| 008 | 201609s 0 0 eng d | ||
| 022 | _a1744-7674 | ||
| 024 | 7 |
_a10.1517/13543776.2016.1131268 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDonnier-Maréchal, Marion | |
| 245 | 0 | 0 |
_aGlycogen phosphorylase inhibitors: a patent review (2013 - 2015). _h[electronic resource] |
| 260 |
_bExpert opinion on therapeutic patents _c2016 |
||
| 300 |
_a199-212 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzazepines _xchemistry |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xchemistry |
| 650 | 0 | 4 |
_aGlucose _xmetabolism |
| 650 | 0 | 4 |
_aGlycogen Phosphorylase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xchemistry |
| 650 | 0 | 4 | _aPatents as Topic |
| 650 | 0 | 4 | _aSodium-Glucose Transporter 2 Inhibitors |
| 700 | 1 | _aVidal, Sébastien | |
| 773 | 0 |
_tExpert opinion on therapeutic patents _gvol. 26 _gno. 2 _gp. 199-212 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543776.2016.1131268 _zAvailable from publisher's website |
| 999 |
_c25541148 _d25541148 |
||